Compare Gunung Raja Paksi Tbk. (GGRP) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gunung Raja Paksi Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp290 (market cap 3.58T, 509.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,600 (market cap 11.36T, 518.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.2× Gunung Raja Paksi Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (518.7K versus 509.9K). Which is the better fit depends on your goals.
| GGRP | TSPC | |
|---|---|---|
Market Cap | 3.58T | 11.36T |
Volume | 509.9K | 518.7K |
Lot | 5.1K | 5.19K |
Turnover | 149.44M | 1.33B |
Average Price | 293.07 | 2,566.12 |
Value | 149.44M | 1.33B |
Indicative Equilibrium Price | 296 | 2,520 |
Indicative Equilibrium Volume | 300 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gunung Raja Paksi Tbk.
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
